For a better user experience please update your browser or use Chrome or Firefox browser.
Utilities
Publication detail
HomeUpdate on competition enforcement in the pharmaceutical sector (2018-2022)
European competition authorities working together for affordable and innovative medicines : report from the Commission to the Council and the European Parliament
Update on competition enforcement in the pharmaceutical sector (2018-2022)
European competition authorities working together for affordable and innovative medicines : report from the Commission to the Council and the European Parliament
Latest edition.
Publication metadata
This Report provides an overview of how the Commission and the national competition authorities of the EU Member States (‘European competition authorities’) have enforced EU antitrust and merger rules concerning medicines and certain other medical products in the period 2018-2022. It also reports on how EU competition law served to protect undertakings and consumers during the challenging period of the Covid-19 crisis. It is a follow-up to the previously published Report covering the years 2009-2017.
- Published:
- Corporate author(s): Directorate-General for Competition (European Commission)
- Themes: Competition policy
- Subject: competition law , EU competition policy , market supervision , medical research , pharmaceutical expenses , pharmaceutical industry , pharmaceutical legislation , price regulations
|
PDF
|
|||
| ISSN | ISBN 978-92-68-08396-3 | DOI 10.2763/427709 | Catalogue number KD-02-23-117-EN-N |
|
Paper
|
|||
| ISSN | ISBN 978-92-68-08394-9 | DOI 10.2763/09770 | Catalogue number KD-02-23-117-EN-C |
- Released on EU Publications:
Document viewer
Note:
The publication cannot be displayed in the document viewer. Open web version
You may access it from: Download and languages